Chinese Journal of Stroke ›› 2020, Vol. 15 ›› Issue (09): 942-946.DOI: 10.3969/j.issn.1673-5765.2020.09.004
Previous Articles Next Articles
Received:
2020-06-30
Online:
2020-09-20
Published:
2020-09-20
吴娅,李玮
通讯作者:
李玮 weili.tmmu@qq.com
基金资助:
陆军军医大学临床医学科研人才培养计划(2018XLC2022)
WU Ya, LI Wei. Status of Intravenous Thrombolysis for Acute Perforating Artery Infarcts[J]. Chinese Journal of Stroke, 2020, 15(09): 942-946.
吴娅,李玮. 急性穿支动脉梗死的静脉溶栓治疗现状[J]. 中国卒中杂志, 2020, 15(09): 942-946.
[1] POWERS W J,RABINSTEIN A A,ACKERSONT,et al. Guidelines for the early management ofpatients with acute ischemic stroke:2019 updateto the 2018 guidelines for the early management ofacute ischemic stroke:a guideline for healthcareprofessionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2019,50(12):e344-e418[2020-06-30]. https://doi.org/10.1161/STR.0000000000000211.[2] JOHNSTON S C,EASTON J D,FARRANT M,et al. Platelet-oriented inhibition in new TIA andminor ischemic stroke(POINT)trial:rationale anddesign[J]. Int J Stroke,2013,8(6):479-483.[3] WANG Y J,WANG Y L,ZHAO X,et al.Clopidogrel with aspirin in acute minor stroke ortransient ischemic attack[J]. N Engl J Med,2013,369(1):11-19.[4] LEE M,SAVER J L,HAO Q,et al. Anteriorchoroidal artery ischaemic patterns predict outcomeof carotid occlusion[J]. J Neurol NeurosurgPsychiatry,2012,83(6):586-590.[5] CAPLAN L R. Intracranial branch atheromatousdisease:a neglected,understudied,and underusedconcept[J]. Neurology,1989,39(9):1246-1250.[6] ENRIQUEZ-MARULANDA A,AMAYAGONZALEZP,OROZCO J L,et al. Pontinewarning syndrome:a chameleon of ischemicstroke[J]. Neurologist,2016,21(6):93-96.[7] MCLEOD D D,BEARD D J,PARSONS M W,et al.Inadvertent occlusion of the anterior choroidal arteryexplains infarct variability in the middle cerebralartery thread occlusion stroke model[J/OL]. PLoSOne,2013,8(9):e75779[2020-06-30]. https://doi.org/10.1371/journal.pone.0075779.[8] GAO S,WANG Y J,XU A D,et al. Chineseischemic stroke subclassification[J/OL]. Front Neurol,2011,2:6[2020-06-30]. https://doi.org/10.3389/fneur.2011.00006.[9] CHAUSSON N,JOUX J,SAINT-VIL M,et al.Infarction in the anterior choroidal artery territory:clinical progression and prognosis factors[J]. JStroke Cerebrovasc Dis,2014,23(8):2012-2017.[10] KOPPSACHILIS N,PEFKIANAKI M,MARINESCU A,et al. Giant cell arteritispresenting as choroidal infarction[J/OL]. Case RepOphthalmol Med,2013,2013:597398[2020-06-30].https://doi.org/10.1155/2013/597398.[11] YANG L,QIN W,LI Y,et al. Differentiationof pontine infarction by size[J/OL]. Open Med(Wars),2020,15:160-166[2020-06-30]. https://doi.org/10.1515/med-2020-0025.[12] WILSON L K,PEARCE L A,ARAUZ A,et al.Morphological classification of penetrating arterypontine infarcts and association with risk factors andprognosis:the SPS3 trial[J]. Int J Stroke,2016,11(4):412-419.[13] YANG L,QIN W,ZHANG X Y,et al. Infarctsize may distinguish the pathogenesis of lacunarinfarction of the middle cerebral artery territory[J/OL]. Med Sci Monit,2016,22:211-218[2020-06-30].https://doi.org/10.12659/msm.896898.[14] WU M C,TSAI L K,WU C C,et al. Thrombolytictherapy is an only determinant factor for strokeevolution in large anterior choroidal arteryinfarcts[J]. J Stroke Cerebrovasc Dis,2014,23(5):1089-1093.[15] TAKEDA H,TAKAGI M,YAMMAMOTO Y,etal. Branch atheromatous disease:how do we analyzeits pathophysiology and treat it to prevent theprogression of neurological symptoms?[J]. RinshoShinkeigaku,2010,50(11):921-924.[16] DE LOS RÍOS LA ROSA F,KHOURY J,KISSELAB M,et al. Eligibility for intravenous recombinanttissue-type plasminogen activator within a population:the effect of the European Cooperative Acute StrokeStudy(ECASS)Ⅲ Trial[J]. Stroke,2012,43(6):1591-1595.[17] SMAHA L A,American Heart Association. TheAmerican Heart Association get with the guidelinesprogram[J/OL]. Am Heart J,2004,148(5 suppl):S46-S48[2020-06-30]. https://doi.org/10.1016/j.ahj.2004.09.015.[18] POWERS W J,RABINSTEIN A A,ACKERSONT,et al. 2018 guidelines for the early management ofpatients with acute ischemic stroke:a guideline forhealthcare professionals from the American HeartAssociation/American Stroke Association[J/OL].Stroke,2018,49(3):e46-e110[2020-06-30].https://doi.org/10.1161 /STR.0000000000000158.[19] LI W,WU Y,LI X S,et al. Intravenous tirofibantherapy for patients with capsular warningsyndrome[J]. Stroke Vasc Neurol,2019,4(1):22-27.[20] PARK M G,OH E H,KIM B K,et al. Intravenoustissue plasminogen activator in acute branchatheromatous disease:Does it prevent earlyneurological deterioration[J/OL]. J Clin Neurosci,2016,33:194-197[2020-06-30]. https://doi.org/10.1016/j.jocn.2016.04.011.[21] CHENG Z,DUAN H L,MENG F H,et al. Acuteanterior choroidal artery territory infarction:aretrospective study[J/OL]. Clin Neurol Neurosurg,2020,195:105826[2020-06-30]. https://doi.org/10.1016/j.clineuro.2020.105826.[22] DEGUCHI I,HAYASI T,KATO Y,et al.Treatment outcomes of tissue plasminogen activatorinfusion for branch atheromatous disease[J/OL]. J Stroke Cerebrovasc Dis,2013,22(7):e168-e172[2020-06-30]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.10.012. [23] BUSH H S. Combination pharmacotherapy withreduced-dose fibrinolytic and platelet GP Ⅱb/Ⅲainhibition[J]. J Emerg Med,2003,25(4):421-426.[24] ZHU Y,CARMELIET P,FAY W P,et al.Plasminogen activator inhibitor-1 is a majordeterminant of arterial thrombolysis resistance[J].Circulation,1999,99(23):3050-3055.[25] LI W,LIN L,ZHANG M,et al. Safety andpreliminary efficacy of early tirofiban treatment afteralteplase in acute ischemic stroke patients[J]. Stroke,2016,47(10):2649-2651.[26] PANTONI L,FIERINI F,POGGESI A.Thrombolysis in acute stroke patients with cerebralsmall vessel disease[J]. Cerebrovasc Dis,2014,37(1):5-13.[27] HE L Y,XU R H,WANG J,et al. Capsular warningsyndrome:clinical analysis and treatment[J]. BMCNeurol,2019,19(1):285.[28] The National Institute of Neurological Disordersand Stroke rt-PA Stroke Study Group. Tissueplasminogen activator for acute ischemic stroke[J].N Engl J Med,1995,333(24):1581-1588.[29] HACKE W,KASTE M,BLUHMKI E,et al.Thrombolysis with alteplase 3 to 4.5 hours afteracute ischemic stroke[J]. N Engl J Med,2008,359(13):1317-1329. |
[1] | LU Yan, YANG Baorong, HUANG Xiangping, YANG Guangui, CHEN Shengwen, LI Jianrong, ZENG Xiaoming. MRI-Guided Thrombolysis beyond Time Window in Acute Ischemic Stroke in a County-Level Hospital: A Case-Control Study [J]. Chinese Journal of Stroke, 2022, 17(12): 1321-1326. |
[2] | ZHANG Junliang, HUANG Shuangfeng, XU Luyao, XIANG Wei, ZHANG Manman, LIANG Zhigang. Safety and Efficacy of Tirofiban in the Treatment of Mild to Moderate Non-Cardiogenic Ischemic Stroke Screened by MRI [J]. Chinese Journal of Stroke, 2022, 17(01): 66-72. |
[3] | CAO Shuangshuang, ZHANG Xiaoyan, WANG Jianwei, ZHAO Lei, CHEN Hongbing, WANG Mingyu. The Related Factors of Early Neurological Deterioration after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2021, 16(12): 1253-1258. |
[4] | ZHANG Xin-Miao, WANG Chun-Juan, YANG Xin, GU Hong-Qiu, JIANG Ying-Yu, WANG Yi-Long, ZHAO Xing-Quan, LI Zi-Xiao, WANG Yong-Jun. Safety of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Antithrombotic Therapy before Stroke Onset [J]. Chinese Journal of Stroke, 2021, 16(11): 1110-1114. |
[5] | LI Xiao-Gang, YANG Dong-Dong, HU Bo, ZHOU Cheng-Fang, LI Wen-Tao, ZHUANG Hui-Kui, ZHOU Pei-Yang, WANG Qing-Song, CHEN Hui-Ru, SONG Ying-Min, SONG Dong-Jing, CUI Jian-Zhong, WANG Hua-Gang. Efficacy and Safety of Naomaili Granules in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2021, 16(10): 1011-1015. |
[6] | YU Feng-Chun, QI Yan-Yan, ZHANG Jing, GAO Bing, WANG Xue-Hong, ZHAO Feng-Li, WANG Su-Li, FANG Zhi-Yong, QIAO Shu-Dong, BI Qi. Safety and Efficacy of 50 mg Enteric Sustained-Release Aspirin Tablet in Secondary Prevention of Mild Ischemic#br# Stroke/Transient Ischemic Attack#br# [J]. Chinese Journal of Stroke, 2021, 16(07): 657-663. |
[7] | WANG Zhen, XU Wei, HE Guo-Hua, HU Jue, FENG Tie-Qiao, TONG Yang-Ping, XU Gui-Lan, XIAO Hui, YI Hai-Bo, SONG Zhi. Clinical Features and Prognosis of Remote Parenchymal Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2021, 16(07): 680-686. |
[8] | LI Li-Jun, ZHANG Ning, CHEN Qi, WANG Chun-Xue. Mindfulness Training on Post-stroke Depression: A Meta Analysis [J]. Chinese Journal of Stroke, 2021, 16(05): 502-507. |
[9] | CHEN Ying, GAO Ya-Li, LIN Fang-Ju, JIA Wei-Hua. Clinical Analysis and Literature Review of Intravenous Thrombolysis in Acute Ischemic Stroke with Active Malignancy [J]. Chinese Journal of Stroke, 2021, 16(02): 130-135. |
[10] | HUANG Li-Hong, LIU Guang-Wei. A Review on Risk Factors Associated with Poor Prognosis after Intravenous Thrombolysis in Ischemic Stroke Patients [J]. Chinese Journal of Stroke, 2020, 15(12): 1352-1359. |
[11] | LIU Tao,LAN Chun-Wei, YUAN Kun-Xiong, WANG Qing-Yong, LI Kai-Feng, HE Xiong-Jun, LIU Ya-Jie, ZHANG Liang. Efficacy and Safety of Endovascular Therapy for Minor Stroke due to Acute Large Vessel Occlusion [J]. Chinese Journal of Stroke, 2020, 15(10): 1088-1093. |
[12] | LIU Hui-Hui, JIANG Qian-Mei, DAI Jing,LIU Chun-Feng. Advances in Intravenous Thrombolysis for Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2020, 15(09): 934-941. |
[13] | MA Can-Can, ZHANG Xi-Bin, LI Xiao-Bo, CHEN Bei-Lei, LI Jun, JING Jian. Efficacy and Safety of Alteplase Intravenous Thrombolysis in Elderly Patients with Acute Cerebral Infarction [J]. Chinese Journal of Stroke, 2020, 15(09): 972-977. |
[14] | CHEN Zhong-Lun, ZHANG Shan-Shan, ZHANG Xian-Wen, LI Zhao-Kun,PU Ming-Jun, DU Hong-Cai, DUAN Jin-Feng. Intravenous Thrombolysis for Acute Ischemic Stroke Patients with Fluctuating Clinical Symptoms in the Perivenous Thrombolysis Time Window [J]. Chinese Journal of Stroke, 2020, 15(09): 1010-1014. |
[15] | ZHUO Zi-Liang, NIE Zhi-Yu, LIU Yuan-Hua, ZHEN Guo-Jiang,MAO Xiang-Ru, LIU Meng, LIU Wu-Chao. Correlation between Total Burden of Cerebral Small Vessel Disease and Outcome after Intravenous Thrombolysis in Acute Ischemic Stroke Patients [J]. Chinese Journal of Stroke, 2020, 15(07): 734-739. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||